The CONCEPT team exhibited and presented at the “European Cell and Gene Therapy Congress
for Groundbreaking Manufacturing, Commercialisation and Analytical Strategies Conference” on the 4-6 Dec 2023 at the Convention Centre Dublin, Ireland.
Director of CONCEPT, Dr Jonathan Bones presented “Characterisation of AAV on Multiple Levels Using Liquid Phase Separations Coupled to Mass Spectrometry.”
His session demonstrated advanced analytical techniques for characterizing adeno-associated viral vectors, providing practical solutions for AAV gene therapy manufacturing challenges.